Skip to main content
Molecules logoLink to Molecules
. 2016 Oct 25;21(10):1412. doi: 10.3390/molecules21101412

Correction: Chae, H.S.; et al. Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1. Molecules 2016, 21, 1169

Hee-Sung Chae 1, Young-Mi Kim 1, Young-Won Chin 1,*
Editor: Derek J McPhee1
PMCID: PMC6272955  PMID: 27792126

The authors wish to make the following correction to their paper [1]. In Panel D of Figure 2, the data was incorrectly displayed. The correct version of Figure 2D is as follows:

Figure 2.

Figure 2

(D) HMC-1 was treated with the indicated concentrations of Atractylodin for 0.5 h prior to being incubated with PMA (50 nM) plus A23187 (1 μM) for 0.5 h and phospho and total NPM-ALK, AKT, PLCγ1, JAK2, and STAT3 were detected by immunoblot analysis as described in Materials and Methods.

The change does not affect the scientific results. The manuscript will be updated and the original will remain online on the article webpage. The authors would like to apologize for any inconvenience caused to readers by these changes.

Reference

  • 1.Chae H.S., Kim Y.M., Chin Y.W. Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1. Molecules. 2016;21:1169. doi: 10.3390/molecules21091169. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES